Golgi protein 73 versus serum α-fetoprotein as tumor markers for hepatocellular carcinoma in patients with hepatitis C cirrhosis
Egyptian Liver Journal, ISSN: 2090-6226, Vol: 8, Issue: 1, Page: 17-22
2018
- 4Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures4
- Readers4
Article Description
Background/aim Hepatocellular carcinoma (HCC) is categorized as the firth most common type of malignancy and the third most common cause for cancer-related mortality. HCC has been growing in Egypt, with a doubling in the incidence rate in the previous 10 years owing to high prevalence of hepatitis C virus (HCV) in Egypt. Approximately 21% of Egyptian patients have cirrhosis, so the incidence of HCC is increasing. This work was to compare the diagnostic validity of Golgi protein 73 (GP-73) level versus α-fetoprotein (AFP) as tumor markers in HCC on top of HCV-related cirrhosis. Patients and methods Patients were selected from those who attending the HCC outpatient clinic at Specialized Medical Hospital in Mansoura University. Overall, 90 patients were enrolled in this study and divided into three groups: group I had 45 patients with HCC on top of liver cirrhosis due to chronic HCV, group II had 30 patients with liver cirrhosis owing to chronic HCV, and group III had 15 healthy control. Results AFP showed, at a cut-off level of greater than or equal to 69.6 ng/dl, sensitivity and specificity for HCC detection were 71.1 and 93.3%, respectively, whereas GP-73 showed, at a cut-off level greater than or equal to 16.25 ng/dl, sensitivity and specificity for detection of HCC were 71.1 and 63.3%, respectively. Conclusion Serum GP-73 level at cut-off value of 16.25 ng/ml can be used as a diagnostic marker for HCC in patients with chronic HCV. However, it is not superior to AFP as both of them had the same sensitivity, but AFP showed higher specificity. Combination of both increases the sensitivity.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85058780466&origin=inward; http://dx.doi.org/10.1097/01.elx.0000530581.13471.23; http://Insights.ovid.com/crossref?an=01438841-201801000-00004; http://journals.lww.com/eglj/Fulltext/10.1097/01.ELX.0000530581.13471.23; https://dx.doi.org/10.1097/01.elx.0000530581.13471.23; https://login.wolterskluwer.com/as/obVkkeMeVs/resume/as/authorization.ping
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know